Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bayer
Company Monitoring Page for Bayer
latest headlines for company on cafepharma
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
Fierce Pharma
Tue, 03/1/22 - 10:04 pm
Tags:
Bayer
,
Eylea
,
Xarelto
,
drug launches
Kodiak's Eylea rival hits 'major disappointment' with failure in first of 6 phase 3 studies
Fierce Biotech
Wed, 02/23/22 - 09:28 pm
Tags:
Kodiak Sciences
,
KSI-301
,
Eylea
,
Bayer
,
Regeneron
Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J
Fierce Pharma
Fri, 02/18/22 - 10:35 am
Tags:
Bayer
,
Nubeqa
,
prostate cancer
Latest data on Bayer's Essure show more patients had device removed: FDA
Medtech Dive
Tue, 02/15/22 - 10:43 am
Tags:
Bayer
,
Essure
,
devices
,
patients
,
contraceptives
,
Medtech
,
FDA
Bayer-owned AskBio will shift focus toward its doggybone DNA in restructure with Touchlight
Endpoints
Wed, 02/9/22 - 10:47 pm
Tags:
AskBio
,
Bayer
,
DNA
,
dbDNA
,
Touchlight
Bayer-led project on AI in trials eyes ‘virtual’ placebo groups
Pharmaforum
Fri, 02/4/22 - 12:53 pm
Tags:
Bayer
,
placebos
,
artificial intelligence
,
clinical trials
Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets
BioSpace
Fri, 02/4/22 - 11:09 am
Tags:
Bayer
,
Evotec
,
BAY1817080
,
eliapixant
Roche grabs FDA okay for would-be blockbuster eye drug faricimab
Pharmaforum
Mon, 01/31/22 - 10:51 am
Tags:
Roche
,
faricimab
,
Eylea
,
Bayer
,
Regeneron
,
FDA
Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box
Endpoints
Tue, 01/25/22 - 10:48 am
Tags:
Cellino
,
funding
,
Bayer
,
cell therapy
,
regenerative medicine
Bayer jumps on board Mammoth's ultra-small CRISPR tech with sights set first on liver disease
Endpoints
Mon, 01/10/22 - 11:28 am
Tags:
Bayer
,
CRISPR
,
Jennifer Doudna
,
Mammoth Biosciences
Bayer Commits to 100 Percent Green Packaging by 2030
Xtalks
Wed, 12/29/21 - 11:09 am
Tags:
Bayer
,
environmental concerns
,
packaging
Bayer targets 100% green packaging for consumer health brands by 2030 as part of €100 million sustainability plan
Fierce Pharma
Tue, 12/14/21 - 11:19 am
Tags:
Bayer
,
environmental concerns
,
consumer health
,
sustainability
Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer
Pharmaforum
Fri, 12/3/21 - 10:33 am
Tags:
Bayer
,
Nubeqa
,
castration-resistant prostate cancer
,
prostate cancer
,
clinical trials
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Fierce Biotech
Tue, 11/30/21 - 10:41 am
Tags:
MEI Pharma
,
blood cancer
,
follicular lymphoma
,
zandelisib
,
Bayer
,
Gilead Sciences
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Tags:
Parkinson's Disease
,
Levodopa
,
gene therapy
,
Voyager Therapeutics
,
Bayer
Synbio startup GRObio gets $25M to work with new building blocks for protein drugs
MedCity News
Wed, 11/3/21 - 11:31 pm
Tags:
GRObio
,
Harvard
,
funding
,
Bayer
,
protein therapeutics
Bayer, One Drop launch AI tool for heart disease prevention
Pharmaforum
Wed, 10/27/21 - 11:39 pm
Tags:
Bayer
,
One Drop
,
digital health
,
artificial intelligence
,
cardiovascular disease
Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report
Endpoints
Fri, 10/15/21 - 10:57 am
Tags:
CureVac
,
Bayer
,
vaccines
,
COVID-19
,
MRNA
,
drug manufacturing
Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated
Fierce Biotech
Fri, 10/8/21 - 10:39 am
Tags:
IPOs
,
Pyxis Oncology
,
Pfizer
,
Bayer
,
oncology
Bayer drops $460M into contraceptive manufacturing sites with the United Nations' backing
Endpoints
Thu, 10/7/21 - 12:21 pm
Tags:
Bayer
,
drug manufacturing
,
contraceptives
,
United Nations
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.